Roche Introduces Cobas Infinity Edge, a New Open Digital Ecosystem for Point of Care Professionals, Driving Improved Patient Outcomes and Operational Efficiencies in Healthcare
Roche (SIX: RO, ROG; OTCQX: RHHBY) today introduced cobas ® infinity edge, a secure and encrypted cloud-based platform for the integration and management of point of care data, available for use in clinical settings globally.
More people are using digital technologies in health than ever before. Only 15% of healthcare organisations are fully equipped to make quick data-driven decisions due to lack of data integration, multiple incompatible IT systems, and other information silos. With longer life expectancies, and more people living with chronic conditions, healthcare systems face growing pressure to manage more patient data and diagnostic information. Digital health ecosystems can help address these challenges.
The cobas ® infinity edge platform supports healthcare professionals in overcoming these challenges by bringing multiple capabilities together in one digital health ecosystem. Using applications, it facilitates professionals’ ability to view and manage patient test results compliantly, while allowing the integration of this data into patients’ electronic medical records (EMRs). It allows deploying new applications in a point of care device, such as the cobas ® pulse glucose meter, and connecting patient health information from this device in an easy, timely, secure way to various IT systems. Concurrently, it allows health professionals to access a marketplace of medically relevant applications to drive adoption of digital tools that improve patient care, by leveraging Roche’s network of third party developers. Bringing all of these capabilities together, it breaks down information silos, ultimately driving improved patient care and operational efficiency within and across point of care clinical settings and hospital departments.
“Roche is pioneering digital innovations to solve operational and clinical challenges in healthcare,” says Thomas Schinecker, CEO Roche Diagnostics. “With cobas® infinity edge, we are introducing the infrastructure for a digital ecosystem in point of care. We have combined our ability to connect health data safely, securely and compliantly plus our deep healthcare expertise with a unique marketplace, where professionals can use Roche or third-party digital health solutions. We can accelerate digital adoption in healthcare and deliver access to health information anytime, anywhere, for improving patient care.”
The cobas® infinity edge solution suite is compliant with ISO27001, the international standard for information security for cloud-based products and compliant with GDPR and HIPAA data privacy regulations. Its digital ecosystem includes technologies to solve specific operational challenges in lab and hospital settings as well as a digital marketplace offering health-relevant applications from Roche and third-party innovative developers.
Following first commercial availability in select markets, Roche Diagnostics plans to offer the new digital platform in other markets globally throughout 2022 and 2023.
People In This Post
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more